Profile data is unavailable for this security.
About the company
Saroja Pharma Industries India Limited is an India-based pharmaceutical and healthcare company. The Company is focused on trading in pharma active pharmaceuticals ingredients (API), pharma intermediates, chemicals, solvents used for pharmaceutical products human and veterinary medicine. It is also engaged in specialty chemical imports and exports as well as supplying the same to the users. Its specialty chemicals and intermediates have wide application in sectors like pharma, agro and chemicals for humans and veterinarians. The Company deals in three types of product category, such as Chemical, Pharma Intermediary, and API. Its chemical products include Liquid Bromine, Ethyl Acetate, Thionyl Chloride, Para Nitro Phenol, Toluene N.G, And Benzyl Chloride. The Company’s API products include Bromhexine HCL BP Grade, Triclabendazole, Fenbendazole BP Vet, Nitroxynil BP Vet, Oxfendazole BP Vet, Albendazole USP, Rafoxanide BP Vet, and Febantel EP, among others.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated2019
- Employees--
- LocationSaroja Pharma Industries India LtdMUMBAI 400080IndiaIND
- Phone+91 2 220810011
- Websitehttps://www.sarojapharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortin Laboratories Ltd | 34.23m | -41.00m | 152.06m | -- | -- | -- | -- | 4.44 | -5.02 | -5.02 | 4.10 | -- | -- | -- | -- | -- | -- | 0.376 | -- | 1.01 | -30.46 | 22.23 | -119.76 | 0.3017 | -- | -6.87 | -- | -- | -26.86 | -40.48 | 76.53 | -- | -- | -- |
| Saroja Pharma Industries India Ltd | -100.00bn | -100.00bn | 188.96m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -9.78 | -- | -6.97 | -- | -- | -- |
| Vilin Bio Med Ltd | -100.00bn | -100.00bn | 265.05m | -- | -- | 3.05 | -- | -- | -- | -- | -- | 6.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.9741 | -- | 0.4159 | -- | -4.27 | -- | -72.38 | -- | -- | -- |
